Search
Now showing items 1-10 of 16
Angioplasty stenting with Sirolimus (Rapamycin) eluting stents in type 2 diabetic patients Angioplastia con stents liberadores de rapamicina en diabéticos tipo 2: Experiencia del Hospital DIPRECA
(2007)
Background: Drug-eluting stents have been developed to reduce the rates of restenosis after coronary angioplasty. Several studies have demonstrated that rapamycin eluting stents are reliable and effective. Aim: To report ...
Fundamento e desenho do teste randomizado PAINT
(Sociedade Brasileira de Cardiologia - SBC, 2009-12-01)
BACKGROUND: We describe the rationale and design for the PercutAneous INTervention with biodegradable-polymer based paclitaxel-eluting or sirolimus-eluting versus bare stents for de novo coronary lesions - PAINT trial. ...
Fundamento e desenho do teste randomizado PAINT
(Sociedade Brasileira de Cardiologia - SBC, 2009)
FUNDAMENTO: Descrevemos as bases teóricas e o formato do "Estudo PAINT - Intervenção percutânea com stents com eluição de paclitaxel ou sirolimus em polímero biodegradável comparados com stents sem recobrimento no tratamento ...
Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio
(Sociedade Brasileira de Cardiologia - SBC, 2012-04-01)
BACKGROUND: There is no consensus regarding the impact of stenting on long-term endothelial function. There have been reports of increased endothelial dysfunction with sirolimus-eluting stents as compared to bare metal ...
Impacto dos stents e do sirolimus por via oral na vasomotricidade coronariana dependente e independente do endotélio
(Universidade Federal de São Paulo (UNIFESP), 2012-05-30)
Rationale: There is no consensus regarding the impact of stenting on long-term endothelial function. There have been reports of increased endothelial dysfunction with Sirolimus-eluting stents as compared to bare metal ...
Randomized Evaluation of Two Drug-Eluting Stents With Identical Metallic Platform and Biodegradable Polymer But Different Agents (Paclitaxel or Sirolimus) Compared Against Bare Stents: 1-Year Results of the PAINT Trial
(WILEY-LISS, 2009)
Objectives: We tested two novel drug-eluting stents (DES), covered with a biodegradable-polymer carrier and releasing paclitaxel or sirolimus, which were compared against a bare metal stent (primary objective). The DES ...
Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trial
(EUROPA EDITIONTOULOUSE CEDEX 6, 2012)
Aims: The long-term clinical performance of drug-eluting stents (DES) coated with biodegradable polymers is poorly known. Methods and results: A total of 274 coronary patients were randomly allocated to paclitaxel-eluting ...
One-year performance of thin-strut cobalt chromium sirolimus-eluting stent versus thicker strut stainless Steel biolimus-eluting coronary stent: a propensity-matched analysis of two international all-comers registries
(Lippincott Williams & Wilkins, 2021)
Objectives Recent improvements in coronary stent
design have focussed on thinner struts, different alloys and
architecture, more biocompatible polymers, and shorter
drug absorption times. This study evaluates safety ...
Angioplastia con stents liberadores de rapamicina en diabéticos tipo 2: Experiencia del Hospital DIPRECA
(Sociedad Médica de Santiago, 2007)